Onsight Ventures — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Cellevatecellevate.cominMay 2025✓ verified
Cellevate develops Cellevat3d nanofiber-based microcarriers and cell culture systems for upstream bioprocessing, used in viral vector, viral vaccine, and stem cell production by gene therapy and biopharmaceutical organizations.
Advanced ManufacturingBiotechDeep TechMedical DevicesNew MaterialsLong Beach, US
Maximilian Ottosson(Founder)inClint Monfort(Executive Officer, Director, Promoter)
Co-investorsIndustrifondenEuropean Investment BankEICEuropean Innovation Council Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.